DNA And Gene Chip Market Overview, Analysis And Demand By 2034

Get 20% Off All Market Studies With Code ONLINE20 – Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends

What Is the Forecasted Market Size of the DNA And Gene Chip Market by 2029?
The dna and gene chip market size has grown rapidly in recent years. It will grow from $8.19 billion in 2024 to $9.2 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to genomic research advancements, rise of personalized medicine, human genome project milestones, drug discovery and development, disease biomarker identification.

The dna and gene chip market size is expected to see rapid growth in the next few years. It will grow to $15.13 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to advancements in precision medicine, expansion of biomarker discovery, growth of personalized therapeutics, application in cancer research, increasing research funding. Major trends in the forecast period include technological advancements, product innovations, regulatory framework and compliance, focus on rare diseases, continuous reduction in costs.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

What Are the Major Drivers Influencing the DNA And Gene Chip Market?
The rising demand for early cancer detection is significantly contributing to the growth of the DNA and gene market. Cancer is a broad class of conditions that can develop in practically any organ or tissue of the body when aberrant cells multiply uncontrollably, cross normal cell boundaries to invade nearby organs, and spread to other regions of the body. DNA and gene chips are used to measure gene expression patterns, determine the genetic and epigenetic landscape, and measure genomic regulatory elements bound by cancer transcription factors in cancerous cells. For instance, in 2022, according to the American Cancer Society, a US-based community-based, voluntary health organization, it is projected that there will be approximately 1.9 million newly diagnosed cancer cases and 609,360 deaths from cancer in the United States. Therefore, rising demand for early cancer detection is driving the growth of the DNA and gene chip market.

Which Are the Leading Segments in the DNA And Gene Chip Market by Revenue?
The dna and gene chipmarket covered in this report is segmented –

1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

Subsegments:
1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays
3) By Other Types: Single-Cell RNA Sequencing Chips, SNP (Single Nucleotide Polymorphism) Chips, Whole Genome Amplification Chips

Which Trends Are Positively Affecting the DNA And Gene Chip Market Expansion?
Strategic partnerships and collaborations are the key trends gaining popularity in the DNA and gene chip market. Many companies operating in this sector looking for partnerships to strengthen their position in the DNA and gene chip market. For instance, in June 2022, Avesthagen Limited, an India-based integrated systems biology platform company, entered into a four-year strategic partnership with Wipro Limited, an India-based information technology company. Through this partnership, both companies execute the project titled Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer project-related genomics sequencing services. Further, in May 2022, Thermo Fisher Scientific, a US-based supplier of analytical instruments, partnered with Qatar Genome Program (QGP), a member of Qatar Foundation (QF) to develop an Axiom custom genotyping array for pan-Arab populations, utilizing whole genome sequencing data from 19 Arab countries. The array, with 800,000 variants, aims to enhance genomic research, focusing on conditions such as diabetes, cardiovascular diseases, autism, and cancer. The collaboration supports Qatar's national vision for improved population health and the advancement of precision medicine for people of Arab identity worldwide. Thermo Fisher's Axiom microarray technology facilitates accelerated precision medicine initiatives.

Who Are the Leading Players in the DNA And Gene Chip Market?
Major companies operating in the DNA and gene chip market are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Cepheid, Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences

Get the full dna and gene chip market report here:
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

What Are the Opportunities and Challenges for DNA And Gene Chip Market Across Regions?
North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company